Novartis Europharm Limited
- A10 - Antidiabéticos
- ICANDRA film-coated tablet 1 000 mg+50 mg
- ICANDRA film-coated tablet 850 mg+50 mg
- JALRA tablet 50 mg
- XILIARX tablet 50 mg
- ZOMARIST film-coated tablet 1 000 mg+50 mg
- ZOMARIST film-coated tablet 850 mg+50 mg
- B02 - Antihemorrágicos
- REVOLADE film-coated tablet 12.5 mg
- REVOLADE film-coated tablet 25 mg
- REVOLADE film-coated tablet 50 mg
- REVOLADE film-coated tablet 75 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- NEPARVIS film-coated tablet 103 mg+97 mg
- NEPARVIS film-coated tablet 26 mg+24 mg
- NEPARVIS film-coated tablet 51 mg+49 mg
- J05 - Antivirales de uso sistémico
- SEBIVO film-coated tablet 600 mg
- L01 - Antineoplásicos
- KISQALI film-coated tablet 200 mg
- MEKINIST film-coated tablet 0.5 mg
- MEKINIST film-coated tablet 2 mg
- PIQRAY film-coated tablet 100 mg
- PIQRAY film-coated tablet 150 mg
- PIQRAY film-coated tablet 50 mg
- RYDAPT capsule, soft 25 mg
- TAFINLAR capsule, hard 50 mg
- TAFINLAR capsule, hard 75 mg
- TASIGNA capsule, hard 200 mg
- TYVERB film-coated tablet 250 mg
- VOTRIENT film-coated tablet 200 mg
- VOTRIENT film-coated tablet 400 mg
- VOTUBIA dispersible tablet 1 mg
- VOTUBIA dispersible tablet 2 mg
- VOTUBIA dispersible tablet 3 mg
- VOTUBIA dispersible tablet 5 mg
- VOTUBIA tablet 10 mg
- VOTUBIA tablet 2.5 mg
- VOTUBIA tablet 5 mg
- ZYKADIA capsule, hard 150 mg
- ZYKADIA film-coated tablet 150 mg
- L04 - Inmunosupresores
- GILENYA capsule, hard 0.25 mg
- GILENYA capsule, hard 0.5 mg
- ILARIS powder for solution for injection 150 mg
- MAYZENT film-coated tablet 0.25 mg
- MAYZENT film-coated tablet 2 mg
- M09 - Otros medicamentos para desórdenes del sistema musculoesquelético
- ZOLGENSMA solution for infusion
- N06 - Psicoanalépticos
- EXELON capsule, hard 4.5 mg
- PROMETAX capsule, hard 1.5 mg
- PROMETAX capsule, hard 3 mg
- PROMETAX capsule, hard 4.5 mg
- PROMETAX capsule, hard 6 mg
- PROMETAX oral solution 2 mg/ml
- PROMETAX transdermal patch 13.3 mg/24 h
- PROMETAX transdermal patch 4.6 mg/24 h
- PROMETAX transdermal patch 9.5 mg/24 h
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- HIROBRIZ BREEZHALER inhalation powder, hard capsule 150 µg
- HIROBRIZ BREEZHALER inhalation powder, hard capsule 300 µg
- ONBREZ BREEZHALER inhalation powder, hard capsule 150 µg
- ONBREZ BREEZHALER inhalation powder, hard capsule 300 µg
- OSLIF BREEZHALER inhalation powder, hard capsule 150 µg
- SEEBRI BREEZHALER inhalation powder, hard capsule 44 µg
- TOVANOR BREEZHALER inhalation powder, hard capsule 44 µg
- ULTIBRO BREEZHALER inhalation powder, hard capsule 85 µg+43 µg
- ULUNAR BREEZHALER inhalation powder, hard capsule 85 µg+43 µg
- XOLAIR powder and solvent for solution for injection 75 mg+0.6 ml
- XOTERNA BREEZHALER inhalation powder, hard capsule 85 µg+43 µg
- ZIMBUS BREEZHALER inhalation powder, hard capsule 114 µg+46 µg+136 µg
- S01 - Oftalmológicos
- IZBA eye drops, solution 30 µg/ml
- LUCENTIS solution for injection 3 mg/0.3 ml
- NEVANAC eye drops, suspension 0.1%
- SIMBRINZA eye drops, suspension 10 mg/ml+2 mg/ml
- TRAVATAN eye drops, solution 0.004%